Persistent Fever and Cancer: When a Fever That Won’t Go Away Is More Than Infection

persistent fever cancer featured

Fever is the body’s primary defense response — a regulated rise in temperature designed to slow bacterial replication and activate immune cells. Most fevers resolve within days. When fever persists for weeks despite no identifiable infection, that’s a fundamentally different clinical situation — and one that demands a thorough investigation.

Cancer accounts for approximately 20–30% of fever of unknown origin (FUO) cases in adults. Understanding why tumors cause fever, which cancers do it most often, and what other clues accompany a cancer-related fever is essential for anyone dealing with a persistent temperature that won’t resolve.

20–30%
of fever of unknown origin cases in adults are caused by cancer
>38.3°C
for >3 weeks with no diagnosis = fever of unknown origin (FUO)
~30%
of Hodgkin lymphoma patients have fever as a B symptom at diagnosis

What Is Fever of Unknown Origin?

FUO has a precise clinical definition: temperature greater than 38.3°C (101°F) on multiple occasions, persisting for more than 3 weeks, without a diagnosis after at least 3 days of inpatient investigation or 3 outpatient visits. The key word is “unknown” — FUO is fever that has been actively investigated with standard tests and still has no explanation.

The three main categories of FUO in adults: infections (~30%), malignancy (~20–30%), and non-infectious inflammatory conditions — autoimmune and rheumatologic diseases (~15–20%). In adults over 40, malignancy becomes increasingly likely as a cause.

How Cancer Causes Persistent Fever

Paraneoplastic Fever (Most Common)

Tumor cells and the macrophages they activate release interleukins (IL-1, IL-6), TNF-α, and interferons. These cytokines stimulate prostaglandin E2 (PGE2) synthesis in the hypothalamus, resetting the thermostat upward. This is genuine fever — involving actual thermoregulatory changes. Because PGE2 is the mediator, NSAIDs (which block PGE2) can suppress this type of fever. This is the basis of the naproxen test.

Tumor Necrosis

Large, rapidly growing tumors develop central necrosis — the interior outgrows its blood supply and begins to die. Necrotic tissue releases pyrogenic material into the bloodstream, producing fever that can be sustained and difficult to control with standard antipyretics.

Secondary Infection from Obstruction

A pancreatic cancer obstructing the bile duct causes ascending cholangitis. A lung cancer obstructing a bronchus causes post-obstructive pneumonia. The fever here is from the infection — but the cancer is the underlying cause. Treatment requires both addressing the infection and managing the obstructing tumor.

The Pel-Ebstein Pattern

One of the most historically distinctive fever patterns in oncology, Pel-Ebstein fever describes a cyclical pattern in Hodgkin lymphoma: days to weeks of elevated temperature alternating with afebrile periods in a regular cycle. Named for two 19th-century physicians who independently described it, Pel-Ebstein fever is rare (5–10% of Hodgkin cases) but is considered highly suggestive when a young patient presents with cyclical fever, unexplained lymphadenopathy, and constitutional symptoms.

Which Cancers Cause Persistent Fever?

Cancer Mechanism Key Features
Hodgkin LymphomaCytokines (IL-6, TNF-α)B symptom; ~30% at diagnosis; Pel-Ebstein pattern
Non-Hodgkin LymphomaCytokinesAggressive subtypes (DLBCL, Burkitt) most common
AML/LeukemiaCytokines + neutropenic infectionDistinguish tumor fever from neutropenic fever — treatment differs
Renal Cell CarcinomaEctopic IL-6, paraneoplastic“Internist’s tumor”; fever in ~20%; may precede urinary symptoms
Hepatocellular CarcinomaTumor necrosis + cytokinesOften on cirrhotic background; fever may be attributed to liver disease
Atrial MyxomaIL-6 production by tumorRare cardiac tumor; triad: emboli + obstruction + constitutional symptoms; mimics lymphoma

The B Symptoms in Lymphoma

In lymphoma staging (Ann Arbor system), three symptoms together constitute “B symptoms” and change the stage designation, prognosis, and treatment approach:

B SYMPTOMS
  1. Unexplained fever greater than 38°C
  2. Drenching night sweats
  3. Unexplained weight loss greater than 10% of body weight in the preceding 6 months

Presence of B symptoms = Stage IIB rather than IIA — typically indicating more aggressive disease and more intensive treatment. Any patient with all three B symptoms and palpable lymphadenopathy needs expedited hematology evaluation.

The Naproxen Test

The naproxen test uses the mechanism of paraneoplastic fever to help distinguish it from infectious fever. Since cancer fever is mediated by PGE2 (which naproxen blocks), tumor-related fever often resolves with naproxen while infectious fever typically does not.

Protocol: Naproxen 375 mg twice daily for 3 days. Complete resolution of fever = positive test, suggesting malignant or inflammatory (not infectious) etiology.

Limitations: The test is not specific — tuberculosis also responds to naproxen. A positive naproxen test adds clinical information but does not replace investigation. It should not be used to conclude “this isn’t cancer” if other red flags are present.

When Persistent Fever Requires Urgent Evaluation

Seek urgent evaluation if persistent fever is accompanied by:
  • Significant weight loss + palpable lymph nodes → lymphoma, evaluate within days
  • Pallor + easy bruising or bleeding → AML, CBC same day
  • Right upper quadrant pain or jaundice → HCC or biliary obstruction
  • Hematuria or flank mass → renal cell carcinoma
  • Fever not responding to antibiotics after 5–7 days in outpatient setting
  • Cyclical fever pattern (Pel-Ebstein) → lymphoma evaluation

What the Workup Looks Like

  • CBC with differential — blasts (AML), lymphocytosis (CLL), thrombocytopenia
  • Comprehensive metabolic panel — liver function (hepatic involvement), kidney function
  • LDH, ESR, CRP, ferritin — markedly elevated in lymphoma; extremely high ferritin (>10,000) suggests HLH or aggressive lymphoma
  • Blood cultures ×2 — endocarditis, bacteremia
  • Chest X-ray — mediastinal widening (Hodgkin lymphoma), pneumonia, mass
  • CT chest/abdomen/pelvis — if initial evaluation non-diagnostic
  • PET-CT + lymph node biopsy — if lymphoma suspected

Frequently Asked Questions

What temperature is considered a cancer-related fever? +
In the lymphoma B symptom criteria, fever is defined as greater than 38°C (100.4°F). For FUO, the threshold is 38.3°C. A single fever resolving in days after a clear viral illness doesn’t meet the concern threshold. Persistence — recurring over 3+ weeks — matters more than the absolute temperature.
Can cancer cause fever without any other symptoms? +
Yes. Renal cell carcinoma and Hodgkin lymphoma both present with isolated fever as the sole symptom in some patients, weeks to months before other findings emerge. This is why unexplained persistent fever — even in otherwise well-appearing patients — is taken seriously by experienced clinicians.
How do doctors distinguish cancer fever from infection fever? +
Blood cultures, inflammatory markers, imaging, and clinical context provide most of the information. The naproxen test can help clinically. If a fever responds to antibiotics, infection is likely; if it doesn’t, or returns when antibiotics are stopped, malignancy or inflammatory disease moves up the list. Ultimately, if infection workup is negative, cancer is investigated with CT imaging and biopsy.
Is fever from cancer always dangerous? +
Paraneoplastic tumor fever itself is generally not life-threatening — it’s a symptom, not a direct mechanism of harm. The danger lies in the underlying cancer. In immunocompromised cancer patients (especially those on chemotherapy), neutropenic fever — fever during a period of very low white blood cells — IS a medical emergency requiring same-day hospitalization and empiric antibiotics.
Medical Disclaimer: This article is for educational purposes only. Persistent fever lasting more than 2–3 weeks without a clear cause requires evaluation by a physician.

References

  1. Mourad O, et al. Fever of Unknown Origin: A Systematic Review. J Hosp Med. 2020.
  2. Lister TA, et al. Ann Arbor classification. J Clin Oncol. 1989.
  3. NCCN Clinical Practice Guidelines: Hodgkin Lymphoma. Version 2024.
  4. Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens. Clin Infect Dis. 2004.
  5. Bleeker-Rovers CP, et al. A prospective multicenter study on fever of unknown origin. Medicine. 2007.
  6. Cunha BA. Fever of unknown origin: the cancer connection. Infect Dis Clin North Am. 2017.